BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, March 24, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2013
View Archived Issues
Servier partners with SIgN for immunomodulatory drugs
Read More
Sanofi's Complavin combination tablets approved in Japan
Read More
Stanford University presents 64Cu-NOTA-B-Fab, an immuno-PET tracer companion diagnostic
Read More
Proximagen begins phase II PRX-167700 study of knee osteoarthritis
Read More
Phase III study of BioMarin's BMN-673 in metastatic breast cancer commences
Read More
Bioheart forms license agreement with Invitrx
Read More
Cornerstone Pharmaceuticals begins phase II CPI-613 trial in MDS
Read More
Torrent Pharmaceuticals presents first clinical data for TRC-150094
Read More
Gemigliptin is safe and efficient as a long-term treatment added to ongoing metformin
Read More
DatSCAN intravenous injection approved in Japan
Read More
Ablynx and Merck Serono expand nanobodies partnership
Read More
Program to evaluate LUM-001 in Alagille syndrome, FDA grants LUM-001 orphan drug designations
Read More
Merck KGaA to renew testing of lung cancer vaccine
Read More
Tetra Discovery receives phase II SBIR grant to develop new depression drug
Read More
Bio-Matrix Scientific provides update on dCellVax for breast cancer
Read More
Novo Nordisk files application to expand approval of liraglutide in Japan
Read More
Mologen submits MGN-1703 IND application with FDA
Read More
Simeprevir obtains first approval in Japan
Read More
CSL Behring gains Japanese approval for Hizentra
Read More
Alnylam Pharmaceuticals reports interim results from phase I ALN-TTRsc trial
Read More
Experimental LTC4S gene overexpression replicates aspirin-induced asthma
Read More
TNF-alpha production inhibitors reported by PuraPharm and Versitech
Read More
Lupin discovers nAChR alpha7 modulators
Read More
Cadila Healthcare divulges discovery of PCSK9 inhibitors
Read More
Merck & Co. prepares and tests novel PAR-1 antagonists
Read More
